
Industrials · Industrial Machinery & Supplies & Components
$215.20
-1.22%
Vol: 431K
Friday, May 1, 2026
IDEX Corporation reported Q1 2026 sales up 8.9% YoY to $886.9M beating consensus, with non-GAAP EPS of $2.00 exceeding estimates by 12.9%. Health & Science Technologies segment grew 17% driven by AI-related projects including data center power and semiconductor applications. Company raised FY26 guidance to organic sales growth of 3-4% and adjusted EPS of $8.35-$8.55. Record Q4 2025 orders of $979M up 20% reported/16% organic. July 2025 acquisition of Micro-LAM complements optical tech solutions. April 2026 CEO Eric Ashleman noted results "ahead of expectations." Stock near 52-week high of $217.16. Analyst consensus Strong Buy with 12-month PT of $229.63 representing 14.41% upside. Stifel recently lowered PT to $241 from $244 on April 14.
IDEX reported Q1 sales of $886.9M with record orders of $988.3M and adjusted EPS of $2.00 (14% growth), beating expectations. Organic sales growth of 5% with orders up 10% YoY. HST segment led at 17% organic growth. Adjusted EBITDA margin expanded 50bps to 26%. Company raised full-year organic growth guidance to 3-4%. Share repurchases of $76M in Q1. Analysts remain positive despite some price target cuts.
IDEX Corporation will release Q1 2026 results on April 29, 2026 prior to market open with webcast at 8:00 a.m. CT. Sean Gillen joined as Senior Vice President and CFO effective January 5, 2026 from AAR Corp. The company reported record 2025 sales of $3.46B and a 125th consecutive regular quarterly cash dividend of $0.71. Analyst ratings are highly positive with average price target of $228.86, representing 24.31% upside.
IDEX Corporation will release Q1 2026 earnings on Wednesday, April 29, 2026 prior to market open, with investor conference call at 8:00 AM CT. Stifel lowered its price target on IDEX from $244 to $241 in the last 24 hours. BMO Capital Markets maintains a Hold rating on the stock. The company continues to focus on its fluid and metering technologies business.
IDEX Corporation announced that Q1 2026 results will be released on April 29, 2026, before market open. An investor conference call and webcast will take place at 8:00 a.m. CT with CEO Eric Ashleman and CFO Sean Gillen. Market cap approximately $14.8B with trailing twelve month revenue of $3.5B.
No material news in the last 48 hours.
IDEX Corporation announced Q1 2026 earnings release for April 29, 2026. Pre-market trading shows IEX up $3.85 (2.10%) at $187.34 as of April 10. BMO Capital initiated with Market Perform rating on March 26. D.A. Davidson maintaining Hold rating on March 23.
IDEX Corporation reported record 2025 sales of $3.46 billion (+6% reported, +1% organic) with record Q4 sales of $899.1 million. Company appointed Sean M. Gillen as Senior VP and CFO effective January 5, 2026. Q1 2026 earnings guidance of $1.73-$1.78 EPS and FY2026 guidance of $8.15-$8.35 EPS. Q1 2026 earnings release April 29 with call at 8:00 AM CT. CEO noted order growth momentum in HST segment from AI-related projects including data center power solutions. Declared regular quarterly dividend of $0.71 per share (125th consecutive). Stock at $184.48 with 24.31% upside to $228.86 consensus price target from analysts with Strong Buy rating.
IDEX Corporation reported record 2025 sales of $3.46B, up 6% reported and 1% organic. Record Q4 2025 sales of $899.1M, up 4% reported and 1% organic. Record orders of $979M in Q4, up 20% reported and 16% organically. HST segment showing momentum from AI-related projects including data center power solutions. Announced record 125th consecutive quarterly dividend of $0.71.
No material news in the last 48 hours.
IDEX reported record FY 2025 sales $3.46B (+6%), record Q4 sales $899.1M. Order growth in HST segment from AI projects including data center power. Sean Gillen joined as CFO Jan 5. 125th consecutive dividend $0.71. Q1 2026 earnings April 29. Avg Strong Buy PT $228.86.
IDEX Corporation will release Q1 2026 results on April 29, 2026. The company reported record 2025 sales of $3.46B (up 6% reported, 1% organic) and record Q4 sales of $899.1M. IDEX announced a regular quarterly cash dividend of $0.71 per share, marking the company's 125th consecutive quarterly dividend.
IDEX reported record 2025 sales of $3.46B (+6% reported, +1% organic) with record Q4 sales $899.1M. Company appointed Sean M. Gillen as CFO effective Jan 5 from AAR CORP. Q1 2026 earnings scheduled April 29 at 8am CT. Announced 125th consecutive quarterly dividend $0.71. BMO Capital initiated with Market Perform (March 26). 7 analysts avg Strong Buy, PT $228.86 (+24.31%).
IDEX reported record 2025 sales of $3.46B (+6% reported). Appointed Sean M. Gillen as SVP and CFO effective January 5, 2026. Announced regular quarterly dividend of $0.71 per share (125th consecutive).
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| IEXIDEX | $215.20 | -1.22% | +14.2% | 24.3x | 0.98 | $16.2B |
| PHPARKER | $882.03 | -3.01% | -0.3% | 26.7x | 1.25 | $114.8B |
| ITWILLINOIS | $255.35 | -1.03% | -0.2% | 21.3x | 1.15 | $74.4B |
| GWWWW | $1,149.37 | -1.03% | +4.0% | 23.9x | 1.09 | $55.0B |
| IRINGERSOLL | $77.72 | -2.68% | +1.5% | 20.7x | 1.33 | $31.3B |
| DOVDOVER | $225.78 | -0.28% | +9.1% | 19.5x | 1.25 | $30.5B |
Price above both MAs — bullish structure.